1249253

Shailesh Lavana, M.D. — FEI 3030732638

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 16, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Vadodara (India)

Additional Details

Clinical BA/BE

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance